Compare PERI & CYRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PERI | CYRX |
|---|---|---|
| Founded | 1999 | 1999 |
| Country | Israel | United States |
| Employees | N/A | 1100 |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 412.5M | 419.3M |
| IPO Year | 2005 | 2008 |
| Metric | PERI | CYRX |
|---|---|---|
| Price | $9.82 | $8.74 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 9 |
| Target Price | ★ $14.50 | $12.94 |
| AVG Volume (30 Days) | ★ 432.7K | 398.4K |
| Earning Date | 05-12-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 156.22 |
| EPS | N/A | ★ 1.40 |
| Revenue | N/A | ★ $176,177,000.00 |
| Revenue This Year | $9.95 | $11.06 |
| Revenue Next Year | $1.07 | $8.45 |
| P/E Ratio | ★ N/A | $6.26 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $7.00 | $4.63 |
| 52 Week High | $11.44 | $11.45 |
| Indicator | PERI | CYRX |
|---|---|---|
| Relative Strength Index (RSI) | 61.03 | 57.90 |
| Support Level | $9.14 | $8.01 |
| Resistance Level | $10.25 | $9.32 |
| Average True Range (ATR) | 0.41 | 0.42 |
| MACD | 0.05 | 0.10 |
| Stochastic Oscillator | 65.99 | 97.80 |
Perion Network Ltd is a technology company. It offers online advertising and search solutions to brands, agencies, and publishers through desktop, mobile, and social channels. It connects advertisers to consumers across digital advertising channels, including search advertising, social, display, video, digital audio, digital out of home (DOOH), and Connected TV (CTV) advertising. The company earns prime revenue from search advertising and display advertising services. It operates in the business segment of High Impact Advertising solutions. Geographically, the company generates a majority of its revenue from the United States and the rest from other regions.
CryoPort Inc is a provider of integrated, temperature-controlled supply chain solutions for the life sciences industry, with a focus on supporting the cell and gene therapy market. The company provides services such as temperature-controlled logistics, biostorage, bioservices, cryopreservation solutions, and cryogenic systems manufacturing. It operates through two reportable segments: Life Sciences Services and Life Sciences Products. It generates the majority of its revenue from the Life Sciences Services segment.